By Mrinmay Dey and Jeffrey Dastin (Reuters) -Amazon.com Inc said on Wednesday it had completed its $3.5 billion takeover of primary care provider One Medical, a day after a U.S. Federal Trade Commission (FTC) official announced that the agency would…
By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend…
By Jennifer Rigby (Reuters) -The World Health Organization (WHO) is investigating whether there is any connection between manufacturers whose contaminated cough syrups it has linked to the deaths of more than 300 children in three countries, a person familiar with…
By Jonathan Stempel (Reuters) -A new U.S. lawsuit on Thursday accused Germany's Bayer AG of illegally excluding a Virginia farmworker from a settlement over claims its Roundup weedkiller causes cancer, because she is not a U.S. citizen. The complaint said…
By Mark John (Reuters) - Barely two in five people believe their families will be better off in the future, according to a regular global survey that also identified growing levels of distrust in institutions among low-income households. The Edelman…
By Brendan Pierson (Reuters) -California is suing the United States' leading insulin makers and pharmacy benefit managers, accusing them of using their market power to overcharge patients for the life-saving drug, the state's attorney general announced on Thursday. The lawsuit,…
By Kanishka Singh (Reuters) - A woman in Iowa believed to be the oldest living person in the United States, having lived through historic events ranging from the two world wars and the Great Depression to the Spanish flu and…
By Ahmed Aboulenein WASHINGTON (Reuters) - The U.S. Food and Drug Administration failed to adhere to its own guidance and internal practices during the approval process for Biogen's Alzheimer's drug Aduhelm, which was "rife with irregularities," a congressional report showed…
By Sriparna Roy (Reuters) -The U.S. Food and Drug Administration (FDA) on Thursday approved Elanco Animal Health Inc's drug for cats with a type of diabetes, making it the first oral drug to be approved for the disease in animals.…
(Reuters) -Twitter Inc has rolled back a policy that was aimed at tackling misinformation related to COVID-19 on the social media platform, lending itself to the risk of a potential surge in false claims even as cases rise in China…